Carpenter JK, Moskow DM, Hofmann SG Enhanced mental reinstatement of exposure to improve extinction generalization: A study on claustrophobia and MRI fear. PsyArXiv. 2021;1-46.
Garcia-Palacios A, Hoffman HG, Richards TR, Seibel EJ, Sharar SR Use of virtual reality distraction to reduce claustrophobia symptoms during a mock magnetic resonance imaging brain scan: a case report. Cyberpsychol Behav. 2007 Jun;10(3):485-8. doi: 10.1089/cpb.2006.9926.
King S, Woodley J, Walsh N A systematic review of non-pharmacologic interventions to reduce anxiety in adults in advance of diagnostic imaging procedures. Radiography (Lond). 2021 May;27(2):688-697. doi: 10.1016/j.radi.2020.09.018. Epub 2020 Oct 4.
Pull CB Recent trends in the study of specific phobias. Curr Opin Psychiatry. 2008 Jan;21(1):43-50. doi: 10.1097/YCO.0b013e3282f30086.
Rahani VK, Vard A, Najafi M Claustrophobia Game: Design and Development of a New Virtual Reality Game for Treatment of Claustrophobia. J Med Signals Sens. 2018 Oct-Dec;8(4):231-237. doi: 10.4103/jmss.JMSS_27_18.
Tugwell JR, Goulden N, Mullins P Alleviating anxiety in patients prior to MRI: A pilot single-centre single-blinded randomised controlled trial to compare video demonstration or telephone conversation with a radiographer versus routine intervention. Radiography (Lond). 2018 May;24(2):122-129. doi: 10.1016/j.radi.2017.10.001. Epub 2017 Oct 31.
Vadakkan C, Siddiqui W Claustrophobia. 2022 Jul 20. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK542327/
Efficacy of Immersive Entertainement Glasses in Magnetic Resonance Imaging to Reduce Claustrofobia: Clinical Control Trial
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
